MiMedx Group, Inc. MDXG
3.20 USD -0.05 (-1.54%)
At closeNov 4, 2026, 5:03 PM EST
3.20 0.00 0.00%
After hours · Nov 4, 5:03 PM ET
3.15 Day range 3.44
3.03 52-week range 7.97
- YTD
- -52.73%
- 1 year
- -58.39%
Analyst view
Price target (mean) 12.20 +281.2% upside
Now 3.20
- Target (low)
- 12.00
- Target (mean)
- 12.20
- Target (high)
- 13.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy0
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.075 | 0.07 – 0.08 | 0.07 | +7.1% | 94.73M | +12.7% | 2 |
| Next quarter | 0.085 | 0.08 – 0.09 | 0.07 | +21.4% | 104.97M | +13.0% | 2 |
| Current year | 0.325 | 0.32 – 0.33 | 0.29 | +12.1% | 386.53M | +10.8% | 2 |
| Next year | 0.35 | 0.34 – 0.36 | 0.325 | +7.7% | 418.56M | +8.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 31, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 15, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Feb 27, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 1, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 1, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Jul 2, 2024 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 7, 2024 | Lake Street | Initiated | — | Buy |
| Mar 1, 2024 | Mizuho | Maintained | Buy | Buy |
| Oct 31, 2023 | Mizuho | Maintained | Buy | Buy |
| Oct 27, 2023 | Craig-Hallum | Initiated | — | Buy |
| Aug 2, 2023 | Mizuho | Maintained | Buy | Buy |
| Aug 2, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 21, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 3, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Oct 13, 2022 | Mizuho | Initiated | — | Buy |
| Sep 7, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 14, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 26, 2021 | Northland Capital Markets | Initiated | — | Outperform |
| Mar 19, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Feb 26, 2018 | Lake Street | Downgrade | Buy | Hold |
| Feb 20, 2018 | Needham | Downgrade | Strong Buy | Hold |
| May 23, 2017 | First Analysis | Downgrade | Equal-Weight | Underweight |
| Mar 3, 2017 | Piper Sandler | Initiated | — | Overweight |
| Dec 12, 2016 | UBS | Initiated | — | Sell |
| Nov 8, 2016 | Aegis Capital | Initiated | — | Buy |
| Apr 19, 2016 | Lake Street | Maintained | — | Buy |
| Nov 16, 2015 | Needham | Upgrade | Buy | Strong Buy |
| Oct 30, 2015 | Northland Capital Markets | Upgrade | Market Perform | Outperform |